Impact of Unilateral Magnetic Resonance-Guided Focused Ultrasound Thalamotomy in Quality of Life, Nonmotor Symptoms, and Patient-Reported Outcomes in Essential Tremor
BACKGROUND AND OBJECTIVES: Refractory tremor affects quality of life in patients with essential tremor (ET), often accompanied by nonmotor symptoms (NMS) that further impair daily functioning and well-being. This study aimed to evaluate the effects of magnetic resonance-guided focused ultrasound (MRgFUS) unilateral thalamotomy on quality of life and NMS in patients with refractory ET. METHODS: We conducted a prospective observational study including patients treated with unilateral MRgFUS thalamotomy between February 2022 and March 2025. Evaluations were performed at baseline, Day 7, and 3, 6, and 12 months post-treatment. Tremor severity was assessed using the Clinical Rating Scale for Tremor. Quality of life was measured using the Quality of Life in Essential Tremor Questionnaire and the EuroQol-5-Dimension-5-Level Questionnaire. Depression and anxiety were evaluated via the Geriatric Depression Scale (15-item) and Geriatric Anxiety Inventory. Patient perception was assessed using the Patient Global Impression of Severity and Improvement scales. RESULTS: A total of 187 patients were included; 116 (62.03%) completed 12-month follow-up. Treated side-Clinical Rating Scale for Tremor scores decreased from 17.96 ± 4.55 to 3.77 ± 4.38 at 12 months (P < .001). Quality of life scores (Quality of Life in ET Questionnaire, EuroQol-5-Dimension-5-Level questionnaire) improved significantly at all follow-up (P < .05). Geriatric Depression Scale (15-item) and Geriatric Anxiety Inventory scores were significantly reduced at 6 and 12 months (P < .01). At 12 months, 89.7% of patients described improvement, and 45.22% of patients reported mild tremor at most. CONCLUSION: Unilateral MRgFUS thalamotomy leads to significant, sustained improvements in quality of life and NMS in patients with refractory ET with most patients reporting a marked clinical benefit at 1 year.
Authors
- Antonio González-Crespo (ORCID: https://orcid.org/0000-0003-1174-8818)
- Manel Tardáguila
- Mireia Gea
- Lourdes Ispierto (ORCID: https://orcid.org/0000-0002-1837-9675)
- Dolores Vilas (ORCID: https://orcid.org/0000-0003-3084-053X)
- José Ríos
- Jorge Muñoz
- Ramiro Alvarez
- Raquel Garcia (ORCID: https://orcid.org/0000-0002-0790-0074)
- José Antonio Pérez
Institutions
- Universitat Autònoma de Barcelona (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
Publication Details
- Journal
- Neurosurgery
- Published
- 2026-04-14
- DOI
- https://doi.org/10.1227/neu.0000000000004046
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Instituto de Salud Carlos III